Updated September 2026One plan, four pricesFound review
The same plan carries four different figures depending on insurance and term, and the branded pages contradict each other.
The verdict
Found publishes $169 a month for its compounded GLP-1 plan on a twelve-month prepay, read August 2026, with medication, membership and coaching included. Month to month the same plan is $289 cash. With insurance it is $99 prepaid or $199 monthly. Which molecule a buyer receives is settled by a quiz rather than by the price list.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- $169/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 50 states
Found sells a single compounded GLP-1 plan rather than a menu. Semaglutide and tirzepatide carry the same figure and no per-drug split is published. It also lists branded products, where its own pages disagree about the price.
Who writes the prescription, and what do they see?
A prescriber is reached through the plan and the membership is bundled into the figure rather than billed separately. What Found does not publish is which molecule the prescription will be for: that assignment is quiz-gated, so a buyer commits to a plan before learning what it dispenses.
The bundle is the model. Medication, membership and coaching sit inside one figure, which removes the separate charges that complicate most comparisons. What it adds instead is a four-way price matrix: insured against cash, prepaid against monthly. The advertised figure is the corner that costs the most up front.
What happens when the dose goes up?
Nothing is published about what the plan costs as the dose rises, and the single-plan structure makes that harder to reason about than usual. One figure covers two molecules at unstated doses, so there is no per-dose ladder to read even in principle.
What the price includes
The $169 headline requires twelve months paid in advance. Month to month is $289 cash, which is $120 more for the same plan. Six months at the prepaid rate is $1,014, though reaching it means paying for twelve. A sitewide $100-off checkout promotion was running when the pages were read. On the branded lines the site is inconsistent with itself. The homepage carousel advertises Wegovy from $650 a month; the medication table lists a starting cash price near $199. Zepbound appears at $650 against roughly $299.
What it claims, and what it cites
The plan line is compounded, which means it is not FDA-approved and is not reviewed by the agency before dispensing. The branded lines are approved products. Which of the two a given buyer ends up with is not something the pricing page settles.
Where it holds up, and where it does not
- Strength: Medication, membership and coaching bundled
- Strength: Insurance and cash rates both published
- Strength: Coverage stated across 50 states
- Limitation: The headline needs twelve months prepaid
- Limitation: Month to month costs $120 more
- Limitation: Molecule assignment is quiz-gated
- Limitation: Branded prices contradict across pages
What the evidence says about this kind of treatment
The assessment above is about Found. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will prepay a year and wants coaching and membership inside one figure.
- Wrong for
- A reader who needs to know which molecule they are buying before paying.
How Found compares
| Seller | Who it suits | Go |
|---|---|---|
| Hers | Readers who want a wide catalog and will budget the membership as the main charge | See Hers → |
| NextMeds | A reader who wants one charge covering medication and care, and who treats a rate running under a countdown timer as an intro rather than a standing price. | See NextMeds → |
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
More GLP-1 telehealth sellers reviews: Breeze MedsCare Bare RxCoreAge RxStrut HealthSynergy RxActin
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $169 available monthly?
- No. It is the twelve-month prepaid cash rate. Month to month is $289 cash, or $199 with insurance, read August 2026.
- Which drug does the plan supply?
- Found publishes one figure covering both molecules and assigns the drug through a quiz. The pricing pages do not state which a given buyer receives.
- Why do the branded prices differ across the site?
- The homepage carousel and the medication table disagree: Wegovy appears at $650 a month in one place and near $199 in the other. Both were read in August 2026.
- Is Found legit?
- Found is a GLP-1 telehealth sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Found expensive compared with other GLP-1 telehealth sellers?
- Found publishes a starting figure of $169/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Found below the median, toward the cheaper end. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.